🫀Case Overview

A 63-year-old male presented for a follow-up visit to manage Fabry disease, a rare genetic disorder causing cardiac and renal complications. The patient has end-stage renal disease on hemodialysis, a history of mitral valve repair and tricuspid annuloplasty, and a dual-chamber pacemaker due to complete heart block.

📊 Myomics-assisted cardiac MRI Findings

• LV ejection fraction: 49.9% with left ventricular hypertrophy
• T1 mapping: Low T1 in the septum, high T1 in the inferolateral wall
• ECV mapping: Elevated in the inferolateral wall (suggesting fibrosis)
• Late Gadolinium Enhancement (LGE): 7.7% of LV myocardium, indicating scarring

🔬 Clinical Impact & Takeaways

• Enzyme Replacement Therapy (ERT) is key for disease management, and Myomics’ automated analysis helps in early intervention decisions.
• Arrhythmia risk monitoring is guided by precise LGE quantification, aiding in timely therapy adjustments.
• Myomics streamlines workflow, reducing interpretation time while enhancing diagnostic accuracy.

📢 User's Comment

Myomics enables AI-powered, automated cardiac MRI analysis—providing faster, more precise insights for Fabry disease.

Written by BW Choi, Radiologist